FDA approves Retatrutide this year priced at 4.9% on Polymarket, up 1.6 points, on $597K traded
Infiniti Prediction Markets
FDA approves Retatrutide this year priced at 4.9% on Polymarket, up 1.6 points, on $597K traded
No significant new platform headline in the last 30 minutes; news search recirculated only items already used, banned or web-held (the Kalshi $1 billion / $40 billion…
#PredictionMarkets #Kalshi #Polymarket #DraftKings
A new episode of Stranger Things be released worldwide before Jan 1, 2027 priced at 5.0% on Kalshi, down 3.0 points, on $2.5M traded
PredictionBubbles' culture board, fresh on its Oct. 30, 06:40 UTC crawl at 52 open markets with $108.2M traded, lists the Stranger Things episode contract among its most…
#PredictionMarkets #Kalshi
Full attribution
Full attribution under the Digital Millennium Copyright Act (DMCA), 17 U.S.C. § 512: this article is an original report by Infiniti Intelligence that summarizes the reporting of the publishers named above, links to their original work, and reproduces no protected expression beyond brief factual reference and in-line attribution (“according to the publisher”). All rights in the underlying reporting remain with the publishers listed; nothing here implies endorsement by or affiliation with them. Rights holders may request correction, update or removal through the contact address published at infiniti.w3ai.io.